Signatures of a Successful Immune Response against HCV

针对 HCV 的成功免疫反应的特征

• 批准号: 200293
• 负责人: Shoukry Naglaa H
• 金额: $ 34.28万
• 依托单位: Centre hospitalier de l'Universit de Montral (CHUM)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2010
• 资助国家: 加拿大
• 起止时间: 2010-03-01 至 2013-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=200293&lang=en
• 关键词: Cytokines; Hepatitis C; Liver Disease; Microarrays; T Cell Memory; T Cells

Hepatitis C virus (HCV) infection usually causes a life-long persistent infection in humans that can lead to irreversible liver damage and even cancer. It is estimated that the number of persons currently infected with HCV in the world is approximately 13

丙型肝炎病毒（HCV）感染通常会导致人类终身持续感染，可导致不可逆的肝脏损害。 损伤甚至癌症。据估计，目前世界上感染HCV的人数为 大约13